Symposia: Acute Myeloid Leukemias: Biomarkers and Molecular Markers in Diagnosis and Prognosis
Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Research, Artificial intelligence (AI), Lymphoid Leukemias, Acute Myeloid Malignancies, ALL, Combination therapy, AML, MDS, Fundamental Science, Clinical trials, Apoptosis, Adult, Clinical Practice (Health Services and Quality), Bone Marrow Failure Syndromes, Drug development, Translational Research, Epidemiology, CHIP, Assays, Elderly, Genomics, Bioinformatics, Clinical Research, Hematopoiesis, Checkpoint Inhibitor, Chronic Myeloid Malignancies, Health disparities research, Pediatric, Diseases, Immune mechanism, Neonatal, Treatment Considerations, Biological therapies, Immunology, Immunotherapy, Real-world evidence, Lymphoid Malignancies, Computational biology, Registries, Young adult , Biological Processes, Myeloid Malignancies, Emerging technologies, Survivorship, Technology and Procedures, Gene editing, Molecular biology, Study Population, Profiling, Human, Pathogenesis, Imaging, Measurable Residual Disease , Animal model, Machine learning, Molecular testing, Omics technologies
Type: Poster
Hematology Disease Topics & Pathways:
Research, Artificial intelligence (AI), Lymphoid Leukemias, Acute Myeloid Malignancies, ALL, Combination therapy, AML, MDS, Fundamental Science, Clinical trials, Apoptosis, Adult, Clinical Practice (Health Services and Quality), Bone Marrow Failure Syndromes, Drug development, Translational Research, Epidemiology, CHIP, Assays, Elderly, Genomics, Bioinformatics, Clinical Research, Hematopoiesis, Checkpoint Inhibitor, Chronic Myeloid Malignancies, Health disparities research, Pediatric, Diseases, Immune mechanism, Neonatal, Treatment Considerations, Biological therapies, Immunology, Immunotherapy, Real-world evidence, Lymphoid Malignancies, Computational biology, Registries, Young adult , Biological Processes, Myeloid Malignancies, Emerging technologies, Survivorship, Technology and Procedures, Gene editing, Molecular biology, Study Population, Profiling, Human, Pathogenesis, Imaging, Measurable Residual Disease , Animal model, Machine learning, Molecular testing, Omics technologies
Monday, December 9, 2024: 6:00 PM-8:00 PM
Halls G-H
(San Diego Convention Center)
See more of: Oral and Poster Abstracts
*signifies non-member of ASH